Harrow, Inc. Deferred Income Tax Expense (Benefit)
Harrow, Inc. (HROW) reported Deferred Income Tax Expense (Benefit) of $643.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-11-10
- Harrow, Inc. deferred income tax expense (benefit) for the quarter ending 2024-09-30 was $20.00K.
- Harrow, Inc. deferred income tax expense (benefit) for the quarter ending 2023-06-30 was $0.00.
- Harrow, Inc. deferred income tax expense (benefit) for the quarter ending 2023-03-31 was -$288.00K.
- Harrow, Inc. deferred income tax expense (benefit) for the quarter ending 2017-12-31 was -$851.00K.
- Harrow, Inc. deferred income tax expense (benefit) for fiscal 2019 was $0.00.
- Harrow, Inc. deferred income tax expense (benefit) for fiscal 2018 was $0.00.
- Harrow, Inc. deferred income tax expense (benefit) for fiscal 2017 was -$935.00K.
- Harrow, Inc. deferred income tax expense (benefit) for fiscal 2016 was -$111.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2024-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $643.00K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $623.00K 10-Q · filed 2025-08-11 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$288.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$288.00K 10-Q · filed 2024-05-13 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 | |||
| 2017-12-31 | -$851.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$879.00K derived: sum of 2 quarters · filed 2019-03-12 | -$935.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$84.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$56.00K 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | -$111.00K 10-K · filed 2018-03-08 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |